Literature DB >> 17466020

Regional and phenotype heterogeneity of cellular prion proteins in the human brain.

Thorsten Kuczius1, Richard Koch, Kathy Keyvani, Helge Karch, Jacques Grassi, Martin H Groschup.   

Abstract

Transmissible spongiform encephalopathies (TSEs) are neurological disorders that include genetic, infectious and sporadic forms of human Creutzfeldt-Jakob disease (CJD). The pathogenic agent is the prion protein that is composed of an abnormal isoform (PrP(Sc)) of a host-encoded protein (PrP(C)). Analysis of the relative amounts of PrP(Sc) glycoforms has been used to discriminate between various agents involved in TSE. The distribution and efficiency of conversion to PrP(Sc) can be influenced by differences in the expression of PrP(C). However, little attention has been given so far to the banding patterns of PrP(C). Using four different antibodies recognizing amino- and carboxyl-terminal PrP sequences we analysed the glycoforms of PrP(C) in seven regions of the human brain using brains obtained from six subjects. For determination of the staining intensities, signals were quantified by densitometry and reproducible patterns were accomplished by many repeated immunoblot analyses. When amino-terminal binding antibodies were used for detection, PrP(C) in the frontal neocortex, nucleus lentiformis, thalamus, hippocampus and cerebellum displayed a glycotype with high staining of the diglycosylated isoforms. This was different from patterns in the pons and medulla oblongata, which showed a high intensity of the nonglycosylated isoform, and PrP(C) proteins, approximately 27 kDa in size, exhibited high staining using the carboxyl-terminal binding antibodies. This intense staining followed from an overlay of full-length and truncated PrP(C) isoforms. Furthermore, we found marked differences in the expression of PrP(C). Variations in the processing of PrP(C) may lead to interregional differences in the glycoform composition of PrP(Sc) in human brains.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466020     DOI: 10.1111/j.1460-9568.2007.05518.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  13 in total

1.  Glycosylation-related genes are variably expressed depending on the differentiation state of a bioaminergic neuronal cell line: implication for the cellular prion protein.

Authors:  Myriam Ermonval; Daniel Petit; Aurélien Le Duc; Odile Kellermann; Paul-François Gallet
Journal:  Glycoconj J       Date:  2008-10-21       Impact factor: 2.916

2.  The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes.

Authors:  Helen M J Klemm; Jeremy M Welton; Colin L Masters; Genevieve M Klug; Alison Boyd; Andrew F Hill; Steven J Collins; Victoria A Lawson
Journal:  J Biol Chem       Date:  2012-08-28       Impact factor: 5.157

3.  Prion protein "gamma-cleavage": characterizing a novel endoproteolytic processing event.

Authors:  Victoria Lewis; Vanessa A Johanssen; Peter J Crouch; Genevieve M Klug; Nigel M Hooper; Steven J Collins
Journal:  Cell Mol Life Sci       Date:  2015-08-23       Impact factor: 9.261

4.  The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP.

Authors:  Valeriy G Ostapchenko; Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2008-09-04       Impact factor: 5.469

5.  Propagation of RML prions in mice expressing PrP devoid of GPI anchor leads to formation of a novel, stable prion strain.

Authors:  Sukhvir Paul Mahal; Joseph Jablonski; Irena Suponitsky-Kroyter; Anja Maria Oelschlegel; Maria Eugenia Herva; Michael Oldstone; Charles Weissmann
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

6.  Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid.

Authors:  Laura D'Castro; Adam Wenborn; Nathalie Gros; Susan Joiner; Sabrina Cronier; John Collinge; Jonathan D F Wadsworth
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

7.  Agitation down-regulates immunoglobulin binding protein EibG expression in Shiga toxin-producing Escherichia coli (STEC).

Authors:  Thorsten Kuczius; Wenlan Zhang; Viktor Merkel; Alexander Mellmann; Phillip I Tarr; Helge Karch
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

8.  Regulating factors of PrP glycosylation in Creutzfeldt-Jakob disease--implications for the dissemination and the diagnosis of human prion strains.

Authors:  Etienne Levavasseur; Isabelle Laffont-Proust; Emilie Morain; Baptiste A Faucheux; Nicolas Privat; Katell Peoc'h; Véronique Sazdovitch; Jean-Philippe Brandel; Jean-Jacques Hauw; Stéphane Haïk
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

9.  Regional distribution of anchorless prion protein, PrP226*, in the human brain.

Authors:  Anja Lukan; Maja Černilec; Tanja Vranac; Mara Popović; Vladka Čurin Šerbec
Journal:  Prion       Date:  2014-02-28       Impact factor: 3.931

10.  Copper and Zinc Interactions with Cellular Prion Proteins Change Solubility of Full-Length Glycosylated Isoforms and Induce the Occurrence of Heterogeneous Phenotypes.

Authors:  Svetlana Brim; Martin H Groschup; Thorsten Kuczius
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.